Answers are grounded in this paper and cite their sources.
AIMS: Living with type 1 diabetes can be challenging, and diabetes distress may be overlooked during time-constrained clinical assessments. Screening for diabetes distress with the one-item Problem Areas in Diabetes Scale (PAID)-1, in conjunction with the five-item PAID-5, may offer an efficient method to improve type 1 diabetes assessment. We aimed to evaluate the utility of this approach to identify possible diabetes distress and its clinically significant covariates. METHODS: We performed a retrospective, real-world, cross-sectional study of adults attending a multidisciplinary type 1 diabetes outpatient clinic at a tertiary centre from October 2023 to September 2024, inclusive. Screening was conducted using PAID-5 (incorporating PAID-1) during the initial consultation. RESULTS: There were 160 adults included (median age 38 years [IQR 30-52]; type 1 diabetes duration 16 years [4-24]; n = 138 [86%] were using continuous glucose monitoring [CGM]). PAID-5 median score was 8 [4-12]; 83 individuals (52%) had a score ≥8, indicating possible diabetes distress. Higher diabetes distress screening scores were associated with CGM metrics indicative of hyperglycaemia; no associations were observed with CGM-detected hypoglycaemia. PAID-1 had sensitivity 81% and specificity 96% for PAID-5-detected diabetes distress. CONCLUSIONS: A high prevalence of diabetes distress was detected on screening among adults attending a tertiary type 1 diabetes service. This highlights the importance of psychological assessment and implementation of management strategies for diabetes distress to reduce the burden of living with type 1 diabetes. Our findings support the use of the PAID-1 as a rapid screening tool to assess for diabetes distress.
No takes yet. Share an insight, caveat, or question.
Vu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: